31 related articles for article (PubMed ID: 11304417)
1. Daucosterol regulates JAK2-STAT3 signaling pathway to promote megakaryocyte differentiation.
Zhang Z; Shang G; Lu Z; Hu J; Liu H; Lu T; Lu X
Blood Cells Mol Dis; 2024 Jul; 107():102858. PubMed ID: 38796983
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Activity of Cepharanthine.
Liu K; Hong B; Wang S; Lou F; You Y; Hu R; Shafqat A; Fan H; Tong Y
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446681
[TBL] [Abstract][Full Text] [Related]
3. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.
Bailly C
Phytomedicine; 2019 Sep; 62():152956. PubMed ID: 31132753
[TBL] [Abstract][Full Text] [Related]
4. Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.
Ita M; Halicka HD; Tanaka T; Kurose A; Ardelt B; Shogen K; Darzynkiewicz Z
Cancer Biol Ther; 2008 Jul; 7(7):1104-8. PubMed ID: 18443430
[TBL] [Abstract][Full Text] [Related]
5. Biscoclaurine alkaloid cepharanthine protects DNA in TK6 lymphoblastoid cells from constitutive oxidative damage.
Halicka D; Ita M; Tanaka T; Kurose A; Darzynkiewicz Z
Pharmacol Rep; 2008; 60(1):93-100. PubMed ID: 18276990
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
Gernsheimer T
Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of cepharanthin for chronic idiopathic thrombocytopenic purpura].
Nakayama S; Matsushita A; Ichiba S; Nagai K
Rinsho Ketsueki; 1992 Mar; 33(3):408-9. PubMed ID: 1578649
[TBL] [Abstract][Full Text] [Related]
8. Effects of splenectomy on immune thrombocytopenic purpura in (NZW x BXSB) F1 mice: analyses of platelet kinetics and anti-platelet antibody production.
Mizutani H; Furubayashi T; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S; Ikehara S
Thromb Haemost; 1992 May; 67(5):563-6. PubMed ID: 1519215
[TBL] [Abstract][Full Text] [Related]
9. [In vitro expansion of cord blood megakaryocyte progenitor].
Feng Y; Xiao ZJ; Xu SC; Lu SH; Liu B; Liu JH; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):199-204. PubMed ID: 15960266
[TBL] [Abstract][Full Text] [Related]
10. [High-dose cepharanthin therapy of idiopathic thrombocytopenic purpura].
Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
Rinsho Ketsueki; 1992 Mar; 33(3):405-7. PubMed ID: 1578648
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of cepharanthin in chronic idiopathic thrombocytopenic purpura.
Sato T; Morita I; Fujita H; Ono M; Kimishima A; Tomiyama J; Murota S
Platelets; 2001 May; 12(3):156-62. PubMed ID: 11304417
[TBL] [Abstract][Full Text] [Related]
12. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
